HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.

Abstract
This retrospective study analysed factors affecting engraftment and transfusion requirements of platelets and red blood cells in 303 patients transplanted for acute non-lymphocytic leukemia in first remission from HLA-identical or one-antigen mismatched donors. Multivariant analysis showed that the most important factors affecting the speed of engraftment were drugs used for graft-versus-host disease (GVHD) prophylaxis, the development of acute GVHD and HLA matching. Factors affecting only granulocyte recovery included patient age and sex. The radiation regimen used for preparing patients affected the time to platelet independence. Patients transplanted in laminar airflow rooms took longer to achieve red cell independence and required more units of red cells and platelets than patients transplanted in regular rooms. In addition, ABO incompatibility affected red cell transfusion requirements while GVHD prophylaxis and acute GVHD influenced both red blood cells and platelet support.
AuthorsW Bensinger, F B Petersen, M Banaji, C D Buckner, R Clift, S J Slichter, R Storb, E D Thomas
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 4 Issue 4 Pg. 409-14 (Jul 1989) ISSN: 0268-3369 [Print] England
PMID2673461 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adult
  • Blood Transfusion
  • Bone Marrow Transplantation
  • Female
  • Graft vs Host Disease (pathology)
  • Histocompatibility
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (therapy)
  • Remission Induction
  • Retrospective Studies
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: